Results 161 to 170 of about 4,257 (203)

Antifungal therapies in murine infections by Candida kefyr

Mycoses, 2016
SummaryCandida kefyr is an emerging pathogen able to cause disseminated infection, especially in immunocompromised patients. Although guidelines for the treatment of invasive candidiasis have been published, no specific recommendations against C. kefyr are available.
Marta Sanchis   +3 more
openaire   +2 more sources

Oesophagitis caused by Candida kefyr

Mycoses, 1998
Summary. The unusual case of an oesophagitis caused by Candida kefyr in a patient with squamous cell carcinoma of the oropharynx is reported. The further implementation of C. kefyr in the production of milk products is discussed.Zusammenfassung. Es wird über den außerge‐wöhnlichen Fall einer Oesophagus‐Mykose bei Plattenepithelcarcinom des Oropharynx
H. Listemann   +4 more
openaire   +1 more source

Candida kefyr Endocarditis in a Patient With Hypertrophic Obstructive Cardiomyopathy

The American Journal of the Medical Sciences, 2010
We report an uncommon but emerging fungal pathogen, Candida kefyr, as a causative agent of infective endocarditis in a patient with a known history of hypertrophic obstructive cardiomyopathy. A 74-year-old woman with diabetes type II, hypertrophic obstructive cardiomyopathy, presented with gross hematuria and abdominal pain.
Teena, Chopra   +6 more
openaire   +2 more sources

Case Report of a Tubo-ovarian Abscess Caused by Candida kefyr

Journal of Obstetrics and Gynaecology Canada, 2018
Candida species are harmless commensals of hosts, including humans, but they can cause infection when the immune system is compromised. Infections with non-albicans species can occur, ranging from urinary tract infections to sepsis, especially among patients in intensive care units.The patient, a 37-year-old woman, presented with severe abdominal pain,
Okmen, Firat   +2 more
openaire   +2 more sources

Oesophagitis caused by Candida kefyr.

Mycoses, 1999
The unusual case of an oesophagitis caused by Candida kefyr in a patient with squamous cell carcinoma of the oropharynx is reported. The further implementation of C. kefyr in the production of milk products is discussed.
H, Listemann   +4 more
openaire   +1 more source

Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr

International Journal of Antimicrobial Agents, 2004
The activity of caspofungin (CSP) combined with terbinafine (TRB) against Candida dubliniensis, Candida kefyr and azole-resistant Candida albicans was evaluated in vitro by checkerboard analysis. The combination of CSP with TRB resulted in positive interactive effects in vitro against C. albicans and C. kefyr but not against C. dubliniensis.
C, Gil-Lamaignere, F-M C, Müller
openaire   +2 more sources

Candida kefyr . [Descriptions of Fungi and Bacteria].

Descriptions of Fungi and Bacteria, 1986
Abstract A description is provided for Candida kefyr . Information is included on the disease caused by the organism, its transmission, geographical distribution, and hosts. DISEASE: Candida kefyr is an uncommon cause of superficial and systemic candidosis in humans and animals.
null UK, CAB International, C. Davis
openaire   +1 more source

Production, purification, and characterization of metalloprotease from Candida kefyr 41 PSB

International Journal of Biological Macromolecules, 2017
A thermostable metalloprotease, produced from an environmental strain of Candida kefyr 41 PSB, was purified 16 fold with a 60% yield by cold ethanol precipitation and affinity chromatography (bentonite-acrylamide-cysteine microcomposite). The purified enzyme appeared as a single protein band at 43kDa. Its optimum pH and temperature points were found to
Yavuz, Sevgi   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy